Savant Capital LLC Acquires New Stake in Marsh & McLennan Companies, Inc. $MRSH

Savant Capital LLC acquired a new stake in Marsh & McLennan Companies, Inc. (NYSE:MRSHFree Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund acquired 8,622 shares of the financial services provider’s stock, valued at approximately $1,599,000.

Several other institutional investors and hedge funds have also recently modified their holdings of MRSH. Brighton Jones LLC raised its holdings in shares of Marsh & McLennan Companies by 51.2% in the 4th quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider’s stock valued at $1,856,000 after buying an additional 2,960 shares during the period. Bison Wealth LLC grew its stake in Marsh & McLennan Companies by 39.6% during the 4th quarter. Bison Wealth LLC now owns 3,064 shares of the financial services provider’s stock worth $651,000 after purchasing an additional 869 shares in the last quarter. Glenview Trust co grew its stake in Marsh & McLennan Companies by 10.8% during the 2nd quarter. Glenview Trust co now owns 3,897 shares of the financial services provider’s stock worth $852,000 after purchasing an additional 379 shares in the last quarter. Osterweis Capital Management Inc. grew its stake in Marsh & McLennan Companies by 18,440.0% during the 2nd quarter. Osterweis Capital Management Inc. now owns 927 shares of the financial services provider’s stock worth $203,000 after purchasing an additional 922 shares in the last quarter. Finally, Diversify Advisory Services LLC acquired a new position in Marsh & McLennan Companies during the 2nd quarter worth $1,307,000. Hedge funds and other institutional investors own 87.99% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently commented on MRSH. Piper Sandler lowered their target price on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating for the company in a research note on Tuesday, May 26th. Morgan Stanley lowered their target price on Marsh & McLennan Companies from $195.00 to $190.00 and set an “equal weight” rating for the company in a research note on Monday, April 6th. Barclays lowered their target price on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research note on Wednesday, April 8th. Mizuho lowered their target price on Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating for the company in a research note on Monday, April 13th. Finally, Citigroup raised Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 target price for the company in a research note on Wednesday, May 6th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $203.56.

Get Our Latest Report on MRSH

Marsh & McLennan Companies Stock Performance

NYSE:MRSH opened at $159.73 on Monday. The business’s 50-day simple moving average is $164.87. The firm has a market cap of $77.17 billion, a PE ratio of 19.97, a P/E/G ratio of 2.33 and a beta of 0.62. Marsh & McLennan Companies, Inc. has a 1 year low of $157.74 and a 1 year high of $235.78. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 1.28.

Marsh & McLennan Companies (NYSE:MRSHGet Free Report) last released its quarterly earnings data on Thursday, April 16th. The financial services provider reported $3.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.21 by $0.08. The business had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The firm’s quarterly revenue was up 7.6% on a year-over-year basis. On average, equities research analysts predict that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current year.

Insider Activity

In other news, CEO John Q. Doyle sold 16,655 shares of the company’s stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total transaction of $3,052,861.50. Following the completion of the transaction, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at approximately $21,411,456.30. This represents a 12.48% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.38% of the company’s stock.

Marsh & McLennan Companies Company Profile

(Free Report)

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

Recommended Stories

Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSHFree Report).

Institutional Ownership by Quarter for Marsh & McLennan Companies (NYSE:MRSH)

Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.